35 filings
8-K
KNTE
Kinnate Biopharma Inc
3 Apr 24
Completion of Acquisition or Disposition of Assets
9:28am
8-K
KNTE
Kinnate Biopharma Inc
1 Mar 24
Entry into a Material Definitive Agreement
8:50am
8-K
KNTE
Kinnate Biopharma Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:10am
8-K
KNTE
Kinnate Biopharma Inc
16 Jan 24
Regulation FD Disclosure
4:05pm
8-K
KNTE
Kinnate Biopharma Inc
22 Nov 23
Departure of Directors or Certain Officers
4:05pm
8-K
j5chg4vaklyj05j2c4
15 Nov 23
Other Events
9:00am
8-K
nxt7ruakz1zt68r25 h2
9 Nov 23
Kinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
4:14pm
8-K
gij2ntpb0k0b4gblq
18 Sep 23
Kinnate Biopharma Inc. Announces Pipeline Updates, Strategic Reprioritization and Workforce Restructuring
4:28pm
8-K
4y2cbrepiwpqw
8 Aug 23
Kinnate Biopharma Inc. Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
4:16pm
8-K
6iepq946kwja6i
28 Jul 23
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
ml8 ztfkx4
12 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
p2ft4lg8nmn7ruyy6rbz
11 May 23
Kinnate Biopharma Inc. Reports First Quarter 2023 Financial Results and Recent Corporate Updates
4:15pm
8-K
qz2605 fa4v
17 Apr 23
Results of Operations and Financial Condition
3:15pm
8-K
ft999nz
15 Mar 23
Kinnate Biopharma Inc. Provides Full-Year 2022 Financial Results and Recent Corporate Updates
4:14pm
8-K
k92yt0ai
21 Feb 23
Other Events
4:13pm
8-K
4fd4814iqhw6eb
26 Jan 23
Kinnate Biopharma Inc. Adds Global Business and Oncology Expertise to Board of Directors with Appointment of Jill DeSimone as Independent Director
4:12pm
8-K
s58d44z yq6
10 Nov 22
Kinnate Biopharma Inc. Announces Third Quarter 2022 Financial Results and Recent Corporate Updates
4:26pm
8-K
umw3ejrra4zvo2hkka81
11 Oct 22
Kinnate Biopharma Inc. Announces Recent Corporate Updates, Including on the Ongoing KIN-2787 Monotherapy Dose Escalation from Global Phase 1 Trial
4:17pm
8-K
uwc2er
11 Aug 22
Kinnate Biopharma Inc. Announces Second Quarter 2022 Financial Results and Recent Corporate Updates
4:15pm
8-K
wr6 eyd2f5g6q50zqzoe
15 Jun 22
Submission of Matters to a Vote of Security Holders
4:00pm